Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 11.27% is in line with its 5-year average of 11.52%, around the middle of its 5-year range (-4.05%–18.88%).
0.22% above its 12-month average of 11.25%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 12.10%.
OPERATING MARGIN
11.27%
OPERATING MARGIN AVG TTM
11.25%
OPERATING MARGIN AVG 3Y
9.71%
OPERATING MARGIN AVG 5Y
11.52%
OPERATING MARGIN AVG 10Y
11.54%
OPERATING MARGIN AVG 15Y
13.38%
OPERATING MARGIN AVG 20Y
15.07%
CURRENT VS TTM AVG
+0.22%
CURRENT VS 3Y AVG
+16.07%
CURRENT VS 5Y AVG
-2.18%
CURRENT VS 10Y AVG
-2.37%
CURRENT VS 15Y AVG
-15.76%
CURRENT VS 20Y AVG
-25.23%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-24.36%
vs the sector median at left
Labcorp Holdings Inc.
Market Cap
$25.55B
Operating Margin
11.27%
TTM Avg
11.25%
3Y Avg
9.71%
5Y Avg
11.52%
Market Cap
$25.94B
Operating Margin
14.14%
TTM Avg
14.08%
3Y Avg
14.06%
5Y Avg
16.54%
Market Cap
$26.14B
Operating Margin
28.69%
TTM Avg
28.45%
3Y Avg
28.53%
5Y Avg
27.71%
Market Cap
$24.62B
Operating Margin
31.57%
TTM Avg
14.26%
3Y Avg
15.92%
5Y Avg
12.23%
Market Cap
$24.37B
Operating Margin
20.64%
TTM Avg
20.32%
3Y Avg
22.80%
5Y Avg
22.92%
Market Cap
$28.88B
Operating Margin
12.70%
TTM Avg
13.37%
3Y Avg
13.23%
5Y Avg
14.11%
Market Cap
$21.10B
Operating Margin
44.49%
TTM Avg
47.77%
3Y Avg
49.26%
5Y Avg
45.01%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $25.55B | 11.27% | 11.25% | 9.71% | 11.52% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.94B | 14.14% | 14.08% | 14.06% | 16.54% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.14B | 28.69% | 28.45% | 28.53% | 27.71% |
| Incyte Corporation (INCY)vs › | $24.62B | 31.57% | 14.26% | 15.92% | 12.23% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.37B | 20.64% | 20.32% | 22.80% | 22.92% |
| BioNTech SE (BNTX)vs › | $24.30B | -22.63% | -35.20% | 5.18% | 14.03% |
| Medline Inc. (MDLN)vs › | $27.51B | 6.07% | 8.25% | 6.70% | 6.70% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.88B | 12.70% | 13.37% | 13.23% | 14.11% |
| United Therapeutics Corporation (UTHR)vs › | $21.10B | 44.49% | 47.77% | 49.26% | 45.01% |
| Waters Corporation (WAT)vs › | $30.54B | 28.22% | 28.07% | 28.30% | 28.33% |
Gross Margin
27.9%
Operating Margin
11.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 12.10% |
| 2026-03-31 | 10.95% |
| 2025-12-31 | 10.87% |
| 2025-09-30 | 11.13% |
| 2025-06-30 | 11.18% |
| 2025-03-31 | 9.75% |
| 2024-12-31 | 6.50% |
| 2024-09-30 | 7.74% |
| 2024-06-30 | 9.15% |
| 2024-03-31 | 10.11% |
| 2023-12-31 | -4.05% |
| 2023-09-30 | 8.25% |
| 2023-06-30 | 8.78% |
| 2023-03-31 | 10.86% |
| 2022-12-31 | 2.47% |
| 2022-09-30 | 13.05% |
| 2022-06-30 | 14.67% |
| 2022-03-31 | 17.64% |
| 2021-12-31 | 18.01% |
| 2021-09-30 | 18.88% |
| 2021-06-30 | 18.33% |
| 2021-03-31 | 25.42% |
| 2020-12-31 | 28.80% |
| 2020-09-30 | 26.88% |
| 2020-06-30 | 10.75% |
| 2020-03-31 | -6.82% |
| 2019-12-31 | 11.39% |
| 2019-09-30 | 11.61% |
| 2019-06-30 | 11.65% |
| 2019-03-31 | 11.40% |
| 2018-12-31 | 11.04% |
| 2018-09-30 | 12.13% |
| 2018-06-30 | 12.88% |
| 2018-03-31 | 10.72% |
| 2017-12-31 | 12.67% |
| 2017-09-30 | 12.85% |
| 2017-06-30 | 13.21% |
| 2017-03-31 | 13.60% |
| 2016-12-31 | 13.32% |
| 2016-09-30 | 13.42% |
| 2016-06-30 | 15.09% |
| 2016-03-31 | 12.75% |
| 2015-12-31 | 10.58% |
| 2015-09-30 | 13.24% |
| 2015-06-30 | 14.16% |
| 2015-03-31 | 7.26% |
| 2014-12-31 | 14.48% |
| 2014-09-30 | 15.56% |
| 2014-06-30 | 16.27% |
| 2014-03-31 | 14.21% |
| 2013-12-31 | 14.96% |
| 2013-09-30 | 16.73% |
| 2013-06-30 | 18.34% |
| 2013-03-31 | 18.18% |
| 2012-12-31 | 15.32% |
| 2012-09-30 | 17.27% |
| 2012-06-30 | 19.39% |
| 2012-03-31 | 20.17% |
| 2011-12-31 | 18.12% |
| 2011-09-30 | 17.05% |
| 2011-06-30 | 16.08% |
| 2011-03-31 | 17.23% |
| 2010-12-31 | 18.43% |
| 2010-09-30 | 18.43% |
| 2010-06-30 | 21.84% |
| 2010-03-31 | 19.62% |
| 2009-12-31 | 18.52% |
| 2009-09-30 | 19.82% |
| 2009-06-30 | 20.58% |
| 2009-03-31 | 20.81% |
| 2008-12-31 | 18.26% |
| 2008-09-30 | 17.81% |
| 2008-06-30 | 17.01% |
| 2008-03-31 | 21.85% |
| 2007-12-31 | 18.11% |
| 2007-09-30 | 17.53% |
| 2007-08-01 | 20.37% |
| 2007-03-31 | 20.37% |
| 2006-12-31 | 18.11% |
| 2006-09-30 | 19.34% |
| 2006-06-30 | 20.98% |
| 2006-03-31 | 19.21% |
| 2005-12-31 | 16.51% |
| 2005-09-30 | 17.77% |
| 2005-06-30 | 20.29% |
| 2005-03-31 | 19.72% |
| 2004-12-31 | 17.89% |
| 2004-09-30 | 19.55% |
| 2004-06-30 | 20.94% |
| 2004-03-31 | 19.18% |
| 2003-12-31 | 17.87% |
| 2003-09-30 | 18.01% |
| 2003-06-30 | 19.21% |
| 2003-03-31 | 17.51% |
| 2002-12-31 | 13.58% |
| 2002-09-30 | 14.68% |
